Evolution of the Average Target: Amgen Inc.

Data source: Amgen Inc.(AMGN)
Evolution of the Average Target - Amgen Inc.

Evolution of the Target Price: Amgen Inc.

Data source: Amgen Inc.(AMGN)
Evolution of the Target Price - Amgen Inc.

Changes in Analyst Recommendations: Amgen Inc.

Data source: Amgen Inc.(AMGN)
85d34f3d679bcc128f996.lEp87VK9zua-KfL89Q3-RlvdX8HRc_6jKGSluMtZFKg.rCYwgybLlovPWJ2dgVTOD2KVDKSOQojQHgX0yoE_c-r5EkSJat6rs9EahQ~4722f7eb1899f8f768fabd9c8b744651
11-16 Barclays Adjusts Price Target on Amgen to $430 From $400 MT
11-12 Argus Research Adjusts Amgen Price Target to $515 From $460 MT
11-11 Daiwa Securities Adjusts Price Target on Amgen to $490 From $430 MT
11-06 Guggenheim Adjusts Price Target on Amgen to $435 From $378 MT
11-05 Amgen's Diversified Base Business Warrants Higher Multiple, UBS Says MT
11-05 Amgen's Better-Than-Expected Q3 Results, Guidance Upgrade Support Bullish Outlook, Oppenheimer Says MT
11-05 Scotiabank Adjusts Price Target on Amgen to $530 From $500 MT
11-04 BofA Securities Adjusts Price Target on Amgen to $347 From $328 MT
11-04 Morgan Stanley Adjusts Price Target on Amgen to $410 From $359 MT
11-04 Truist Adjusts Price Target on Amgen to $398 From $380 MT
11-04 Wells Fargo Adjusts Price Target on Amgen to $460 From $430 MT
11-04 Oppenheimer Adjusts Amgen Price Target to $520 From $480 MT
11-04 TD Cowen Adjusts Price Target on Amgen to $531 From $452 MT
11-04 Goldman Sachs Adjusts Price Target on Amgen to $536 From $481 MT
11-04 BMO Capital Adjusts Price Target on Amgen to $442 From $415 MT
11-04 JPMorgan Adjusts Price Target on Amgen to $425 From $350 MT
11-04 UBS Adjusts Price Target on Amgen to $530 From $470 MT
11-04 Canaccord Genuity Adjusts Price Target on Amgen to $440 From $384 MT
11-04 Bernstein Adjusts Price Target on Amgen to $400 From $345 MT
11-04 RBC Capital Adjusts Price Target on Amgen to $470 From $430 MT
11-04 Analyst recommendations: Adobe, AMD, Duolingo, Fortinet, Apple… Zonebourse
11-04 Citigroup Adjusts Price Target on Amgen to $465 From $405 MT
11-02 Wall Street Picks Up the Pieces Zonebourse
10-26 A Week of Reckoning for Wall Street Zonebourse
10-26 Jefferies Adjusts Price Target on Amgen to $428 From $410 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - -
+2.58%
-1.11%
+6.64%
-3.15%
+11.81%
-4.82%
+16.44%
-6.38%
+4.98%
Average +3.00%
Weighted average by Cap. +2.73%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
34
Last Close Price
462.32USD
Average target price
432.84USD
Spread / Average Target
-6.38%
High Price Target
536.00USD
Spread / Highest target
+15.94%
Low Price Target
230.00USD
Spread / Lowest Target
-50.25%

Analyst Consensus Detail

Analyst consensus - Amgen Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Amgen Inc.
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Amgen Inc.